Nissay Asset Management Corp Exact Sciences Corp Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Nissay Asset Management Corp holds 22,066 shares of EXAS stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,066

Previous 21,114 4.51%

Holding current value

$1.27 Million

Previous $892,000 68.39%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $40,393 - $67,430	952 Added 4.51%	22,066 $1.5 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $20,417 - $36,684	494 Added 2.4%	21,114 $892,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $19,300 - $25,303	343 Added 1.69%	20,620 $1.42 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $44,235 - $56,714	749 Added 3.84%	20,277 $1.5 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $57,499 - $86,362	872 Added 4.67%	19,528 $1.33 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $23,567 - $35,738	-376 Reduced 1.98%	18,656 $1.75 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $39,356 - $59,022	-834 Reduced 4.2%	19,032 $1.29 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $880 - $1,541	-29 Reduced 0.15%	19,866 $983,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $30,339 - $46,852	949 Added 5.01%	19,895 $646,000
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $17,199 - $36,819	483 Added 2.62%	18,946 $746,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $27,110 - $38,876	471 Added 2.62%	18,463 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $56,477 - $78,429	779 Added 4.53%	17,992 $1.4 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $82,659 - $113,629	916 Added 5.62%	17,213 $1.64 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $135,245 - $201,105	1,444 Added 9.72%	16,297 $2.03 Million
Q1 2021 May 11, 2021	SELL	$116.57 - $155.01 $42,198 - $56,113	-362 Reduced 2.38%	14,853 $1.96 Million
Q4 2020 Feb 08, 2021	BUY	$99.61 - $142.12 $66,141 - $94,367	664 Added 4.56%	15,215 $2.02 Million
Q3 2020 Oct 20, 2020	BUY	$72.92 - $102.01 $39,960 - $55,901	548 Added 3.91%	14,551 $1.48 Million
Q2 2020 Jul 27, 2020	BUY	$55.75 - $92.75 $85,074 - $141,536	1,526 Added 12.23%	14,003 $1.22 Million
Q1 2020 May 05, 2020	BUY	$37.9 - $104.44 $19,329 - $53,264	510 Added 4.26%	12,477 $724,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $127,440 - $163,673	1,641 Added 15.89%	11,967 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $69,494 - $94,194	769 Added 8.05%	10,326 $933,000
Q2 2019 Aug 07, 2019	BUY	$89.51 - $118.04 $855,447 - $1.13 Million	9,557 New	9,557 $1.13 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Exact Sciences Corp Transaction History